Syncona Share Discussion Threads

[chc15] 16/7/2024 11:25

Noticed this dog is barking again, I've just started a new position here, share price ticking up.

[chrisdgb] 08/7/2024 14:44

Certainly a lot going on...........

[spectoacc] 20/6/2024 08:37

Biased, but I'd say so. Today's RNS's show they're still doing deals.

Those looking at the NAV, and deciding if the discount is large enough, are likely missing that we may be towards the bottom of the cycle. I'd not buy unless I thought that NAV had the potential to go significantly higher over time.

Interestingly, at the top of the cycle when there's money pouring in, they'll be trading at a massive premium and everyone will want to buy.

[dickiehh] 08/6/2024 23:13

Curious as to why this is trading at such a big discount? An opportunity perhaps?

[the shuffle man] 05/6/2024 09:53

Trading at a huge discount to NAV even if you take into account the fall in Autolus shares since the last NAV valuation. All recent news from portfolio companies seems to be positive and the share price has bounced from these levels in the past so i have initiated a position.

[ferrox5] 21/5/2024 12:59

SYNC bought 140K out of 350K traded

[chc15] 20/5/2024 15:52

Yes good bounce, means institutions are buying.

[spectoacc] 20/5/2024 13:57

Perhaps I won't be getting that avg, but not complaining :)

[spectoacc] 17/5/2024 13:10

Needs to hold down here really, otherwise it's all-time lows and then "who knows".

But I do like a cheap share, particularly one ADVFN'ers seem to have gone quiet on.

SYNC still got lots of cash, and Autolus, and most else is in for very little. But needs another sentiment turn on AUTL really.

[chc15] 17/5/2024 11:55

What a dog this is, how long can it go, may be tempted to buy and dump again.

[spectoacc] 17/5/2024 08:23

Autolus seems unable to keep its pants up for long. But SYNC still seems cheap to me, even if sometimes seems the only thing supporting it is the perma-buy back.

Edit - bought back in today. My buys having zero effect on the price, so a good chance I'll be averaging lower, but cheap is cheap.

[chrisdgb] 27/2/2024 11:25

Looking better here.........

[the shuffle man] 02/11/2023 11:52

Autolus looking promising.

[shep22] 29/9/2023 15:36

Desperate stuff.

[the shuffle man] 29/9/2023 10:10

Share buy back seems to have stopped the drop for now.

[shep22] 27/9/2023 22:49

Syncona is in serious decline because of bad management, the issue must be addressed and quickly.

[shep22] 22/9/2023 18:56

Another round of selling coming, management charges urgently required.

[salpara111] 21/9/2023 12:09

I made a small amount of money out of Sync several years ago.
Just having another look again given the bombed out share price
All of these sort of businesses have been hard hit by the rise in interest rates producing a double whammy of increased funding costs for portfolio companies and less opportunity to get an ipo away.
Having said that a point is reached when sentiment is too negative and I think we are nearing that point, having said that, as previous posters have said, the business in now under serious pressure to produce some positive news flow which goes beyond just "we have made good progress with clinical trials"

[chc15] 19/9/2023 19:05

I've learned never to average down on your losers, but average up on your winners. If institutions are dumping this, the only way is down.

[the shuffle man] 18/9/2023 12:06

They need some good news on some of their more mature portfolio companies to try and change this poor sentiment. Hopefully we will hear more news on Autolus soon. Trading at a big discount to NAV and holding a lot of cash. I have done the dreaded thing and averaged down.

[chc15] 18/9/2023 10:31

Yeh gotta be institutions dumping now, wonder if Blackrock have had enough.

[spectoacc] 18/9/2023 09:53

EPIC currently describes the share price :(

[shep22] 12/9/2023 14:02

Can somebody please tell me how Marin Murphy is still in a job, he has destroyed shareholder value.

[tiger blue] 11/9/2023 15:07

Yes, very disappointing. At least they got £326m upfront, so the original decision to sell was a good call. The £54.5m write-off of deferred consideration is equivalent to 8.1p per share, so net asset value is now 176.5p based on the latest quarterly update, of which over 51% is in cash. Discount to asset value is now 32%, so still looking very cheap but this is poor for sentiment and to be honest they need some good news to emerge from their drug portfolio to change that.

[chc15] 11/9/2023 11:46

Oh dear, not good news, I'll hold off buying here. Blackrock must be losing tons on this.